What is the recommended dose of ampicillin (Ampicillin)/sulbactam (Sulbactam) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Ampicillin-Sulbactam for Pediatric Patients

For pediatric patients 1 year of age or older, the recommended dose of ampicillin-sulbactam is 300 mg/kg/day (based on total ampicillin + sulbactam content) administered intravenously in equally divided doses every 6 hours, which corresponds to 200 mg ampicillin/100 mg sulbactam per kg per day. 1

Dosing by Age and Weight

Infants and Children ≥1 Year of Age

  • Standard dosing: 300 mg/kg/day IV divided every 6 hours (q6h), representing the total drug content 1

    • This translates to 200 mg ampicillin/100 mg sulbactam per kg per day 1
    • Alternative guideline recommendation: 100-200 mg ampicillin/kg/day divided every 6 hours 2
  • Children weighing ≥40 kg: Should be dosed according to adult recommendations (1.5-3 g every 6 hours), with a maximum sulbactam dose not exceeding 4 grams per day 1

Infants <1 Year of Age

  • Dosing: 100-150 mg ampicillin/kg/day divided every 6 hours 2
  • Note: The FDA label specifically states that safety and efficacy have not been established for intramuscular administration in pediatric patients 1

Administration Guidelines

Route and Infusion Details

  • Intravenous administration only for the recommended pediatric dosing 1
  • Administer by slow IV injection over at least 10-15 minutes, or as an IV infusion over 15-30 minutes when diluted in 50-100 mL of compatible diluent 1

Duration of Therapy

  • Standard course: Should not routinely exceed 14 days of IV therapy 1
  • In clinical trials, most children transitioned to oral antimicrobials following initial IV treatment 1
  • Average treatment duration in clinical studies was 7 days, with a range of 8-23 days depending on infection severity 3, 4

Special Clinical Contexts

Culture-Negative Endocarditis

  • Native valve endocarditis: 300 mg/kg/day IV in 4-6 equally divided doses for 4-6 weeks 2
  • This represents a higher frequency of administration (every 4-6 hours) compared to standard dosing 2

Renal Impairment

  • Dosing frequency must be reduced in patients with impaired renal function 1
  • The ampicillin-to-sulbactam ratio remains constant regardless of renal function 1
  • Adjust dosing intervals based on creatinine clearance, following the same principles as ampicillin monotherapy 1

Pharmacokinetic and Safety Considerations

Drug Concentrations and Efficacy

  • The 300 mg/kg/day dosing (75 mg/kg q.i.d.) achieves adequate plasma concentrations to cover common pathogens in community-acquired pneumonia 5
  • Peak serum concentrations range from 177-200 mcg/mL for ampicillin and 82-102 mcg/mL for sulbactam 6
  • Clinical cure rates of 95-100% have been demonstrated across various pediatric infections at these doses 3, 4

Safety Profile

  • The combination is well-tolerated in pediatric patients 6
  • Side effects are minimal, with rash occurring in <2% of patients and rarely requiring discontinuation 3
  • Diarrhea may occur but is generally mild 7

Common Pitfalls to Avoid

  • Do not confuse the total drug dose with the ampicillin component alone: The 300 mg/kg/day represents the combined ampicillin + sulbactam content, not just ampicillin 1
  • Do not exceed 4 grams/day of sulbactam in any pediatric patient, regardless of weight 1
  • Do not use intramuscular administration as the standard route in pediatrics, as safety and efficacy have not been established 1
  • Do not extend IV therapy beyond 14 days routinely without reassessing the need for continued parenteral treatment 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sulbactam/ampicillin in the treatment of pediatric infections.

Diagnostic microbiology and infectious disease, 1989

Research

Pharmacokinetics of ampicillin and sulbactam in pediatric patients.

Antimicrobial agents and chemotherapy, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.